T6136 |
Canertinib
|
267243-28-7
|
99.18%
|
|
Canertinib (CI-1033) is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment sig...
|
T6039 |
TAK-285
|
871026-44-7
|
99.17%
|
|
TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Auro...
|
T5410 |
PD158780
|
171179-06-9
|
99.16%
|
|
PD 158780 reversibly inhibits auto and transphosphorylation of all four members of the ErbB receptor superfamily: EGFR, ErbB2, ErbB3, and ErbB4 (IC50s: 8μM, 49 n...
|
T9754 |
BLU-945
|
2660250-10-0
|
99.16%
|
|
BLU-945 is a potent, highly selective, reversible, and orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, effective against EGFR wi...
|
T5168 |
EGFR-IN-12
|
879127-07-8
|
99.15%
|
|
EGFR-IN-12 (EGFR Inhibitor) is a cell permeable and selective inhibitor of EGFR kinase (IC50: 21 nM) and blocks receptor autophosphorylation in cells.
|
T6932 |
PD168393
|
194423-15-9
|
99.13%
|
|
PD168393 is an irreversible EGFR inhibitor (IC50: 0.70 nM), irreversibly alkylate Cys-773; inactive against PKC, FGFR, PDGFR, and insulin.
|
T7649 |
Tyrphostin A1
|
2826-26-8
|
99.13%
|
|
Tyrphostin A1 (Tyrphostin 1) is an inhibitor of EGFR tyrosine kinase .
|
T22396 |
PF-6274484
|
1035638-91-5
|
99.12%
|
|
PF-6274484, a high affinity, irreversible covalent inhibitor of EGFR kinase with Ki of 0.14 nM, inhibits the autophosphorylation of wild-type EGFR in A549 cells ...
|
T3108 |
CUDC-101
|
1012054-59-9
|
99.12%
|
|
CUDC-101 is a potent inhibitor of HDAC, EGFR and HER2 with IC50s of 4.4, 2.4 and 15.7 nM, respectively.
|
T6427 |
Butein
|
487-52-5
|
99.11%
|
|
Butein (2’,3,4,4’-tetrahydroxy Chalcone), a plant polyphenol, is isolated from Rhus verniciflua. It can inhibit the activation of protein tyrosine kinase, NF-κB ...
|
T14336 |
Allitinib
|
897383-62-9
|
99.10%
|
|
Allitinib (AST-1306) (AST-1306) has anti-cancer activity,and it is an irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. [1]
|
T6712 |
Tyrphostin AG 879
|
148741-30-4
|
99.05%
|
|
Tyrphostin AG 879 (AG 879) effectively inhibits HER2/ErbB2 (IC50: 1 μM), 100- and 500-fold higher selective to ErbB2 than EGFR and PDGFR.
|
T36715 |
Tetrac
|
67-30-1
|
99.04%
|
|
Tetrac (Tetraiodothyroacetic acid) is a derivative of L-thyroxine (T4), a thyroxine integrin receptor antagonist.Tetrac induces antiproliferation by blocking EGF...
|
T6619 |
Desmethyl Erlotinib hydrochloride
|
183320-51-6
|
99.03%
|
|
Desmethyl Erlotinib hydrochloride (OSI 420) is an active metabolite of erlotinib which is an orally active EGFR tyrosin kinase inhibitor with IC50 of 2 and 20 nM...
|
T2047 |
AG-1478
|
153436-53-4
|
99.03%
|
|
AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor.
|
T8751 |
AZD8931 diFuMaric acid
|
1196531-39-1
|
99%
|
|
AZD8931 is a reversible and ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 (IC50 of 4 nM, 3 nM and 4 nM, respectively).
|
T3402 |
20(S)-Ginsenoside Rg3
|
14197-60-5
|
98.99%
|
|
20(S)-Ginsenoside Rg3 (Rg3) possess an ability to inhibit the lung metastasis of tumor cells via inhibition of the adhesion and invasion of tumor cells. It inhib...
|
T22974 |
Methyl 2,5-dihydroxycinnamate
|
63177-57-1
|
98.98%
|
|
EGF receptor-associated tyrosine kinases inhibitor
|
T4694 |
AG-1557 hydrochloride (189290-58-2(free base))
|
T4694
|
98.95%
|
|
AG-1557 hydrochloride is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
|
T6733 |
WZ-3146
|
1214265-56-1
|
98.95%
|
|
WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of 2 nM and 2 nM; does not inhibit ERBB2 phosphorylation (T798I)...
|